https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
Medical device maker CooperCompanies (NYSE: COO) has reported a double-digit increase in adjusted earnings for the third quarter of 2025 amid strong sales growth. Third-quarter revenue increased 6% year-over-year to $1.06 billion; CooperVision revenue rose 6% to $718.4 million At $341.9 million, revenues of the CooperSurgical (CSI) business division were up 4% On an adjusted … Read more
Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a 6% revenue growth. CooperComapanies second-quarter revenue increased 6% year-over-year to $1.0 billion, up 7% in constant currency CooperVision revenue rose 5% to $669.6 million in Q2; CooperSurgical revenue moved up 8% to $332.7 … Read more
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in revenues and adjusted profit. First-quarter revenue increased 4% year-over-year to $964. 7 million; CooperVision and CooperSurgical revenues grew 4% and 3%, respectively On a reported basis, earnings per share was $0.52 in Q1, up 27% … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4